Telomere Length Shows No Association with BRCA1 and BRCA2 Mutation Status

This study aimed to determine whether telomere length (TL) is a marker of cancer risk or genetic status amongst two cohorts of BRCA1 and BRCA2 mutation carriers and controls. The first group was a prospective set of 665 male BRCA1/2 mutation carriers and controls (mean age 53 years), all healthy at time of enrolment and blood donation, 21 of whom have developed prostate cancer whilst on study. The second group consisted of 283 female BRCA1/2 mutation carriers and controls (mean age 48 years), half of whom had been diagnosed with breast cancer prior to enrolment. TL was quantified by qPCR from DNA extracted from peripheral blood lymphocytes. Weighted and unweighted Cox regressions and linear regression analyses were used to assess whether TL was associated with BRCA1/2 mutation status or cancer risk. We found no evidence for association between developing cancer or being a BRCA1 or BRCA2 mutation carrier and telomere length. It is the first study investigating TL in a cohort of genetically predisposed males and although TL and BRCA status was previously studied in females our results don''t support the previous finding of association between hereditary breast cancer and shorter TL.     

Kinase-Independent Functions of TEL1 in Telomere Maintenance

TEL1 is important in Saccharomyces cerevisiae telomere maintenance, and its kinase activity is required. Tel1p associates with telomeres in vivo, is enriched at short telomeres, and enhances the binding of telomerase components to short telomeres. However, it is unclear how the kinase activity and telomere association contribute to Tel1p''s overall function in telomere length maintenance. To investigate this question, we generated a set of single point mutants and a double point mutant (tel1^KD) of Tel1p that were kinase deficient and two Xrs2p mutants that failed to bind Tel1p. Using these separation-of-function alleles in a de novo telomere elongation assay, we found, surprisingly, that the tel1^KD allele and xrs2 C-terminal mutants were both partially functional. Combining the tel1^KD and xrs2 C-terminal mutants had an additive effect and resembled the TEL1 null (tel1Δ) phenotype. These data indicate that Tel1p has two separate functions in telomere maintenance and that the Xrs2p-dependent recruitment of Tel1p to telomeres plays an important role even in the absence of its kinase activity.The telomere is a highly ordered complex of proteins and DNA found at the ends of linear chromosomes that functions to protect the ends and prevents them from being recognized as double-strand DNA breaks (51). Telomeres shorten gradually due to incomplete replication (1, 20), and this shortening is counteracted by telomerase, which elongates telomeres (18, 19).Saccharomyces cerevisiae telomeres are composed of 300 ± 50 bp of the sequence TG_1-3/C_1-3A. The yeast telomerase complex consists of Est2p (catalytic subunit), the RNA component TLC1, and two accessory proteins, Est1p and Est3p (50). Cells deficient for any of these telomerase components undergo progressive telomere shortening and a simultaneous decrease in growth rate, described as senescence (24, 27). Typically, a small fraction of cells, termed survivors, escape senescence and maintain telomere length by utilizing RAD52-dependent recombination (24, 26).In addition to the telomerase complex, a number of yeast proteins are important in maintaining telomere length and integrity. These include Tel1p and Mec1p, the yeast homologues of mammalian ATM and ATR, respectively (39). While deletion of TEL1 results in short but stable telomeres, MEC1 deletion has little effect on average telomere length. However, cells lacking TEL1 that have a mutant mec1-21 allele undergo senescence, similar to telomerase null cells (36), suggesting that MEC1 plays a minor but essential role in telomere length maintenance in tel1Δ cells. It has been shown that the protein kinase activities of Tel1p and Mec1p are essential in telomere maintenance, since tel1^KD cells have short telomeres and tel1Δ mec1^KD cells undergo senescence (29).In current models, Tel1p acts to maintain telomere length by regulating the access of telomerase to short telomeres. TEL1 is required for the association of Est1p and Est2p with telomeres in the late S/G₂ phase of the cell cycle (16), the time when telomeres are elongated (9, 31). Additionally, in both yeast and mammalian cells, telomerase preferentially elongates the shortest telomeres (22, 30, 47). Therefore, TEL1 seems to be required mainly for the association of telomerase to short telomeres in yeast. Indeed, Tel1p preferentially binds to short telomeres (4, 21, 38) and is essential for the increased association of Est1p and Est2p to short telomeres during late S/G₂ (38). However, the kinase activity of Tel1p is not required for the telomere association (21). In addition to its role in telomerase recruitment, TEL1 may also regulate telomere length by enhancing the processivity of telomerase at short telomeres (7).The Mre11p, Rad50p, and Xrs2p (MRX) complex also plays important roles in telomere maintenance. Cells lacking any one of these components (mrxΔ) have short and stable telomeres. Since combining mrxΔ with tel1Δ has no synergistic effect on telomere shortening and mrxΔ mec1Δ cells undergo senescence, it was proposed that the MRX complex and Tel1p function in the same telomere maintenance pathway (37). In agreement with this model, the C-terminal region of Xrs2p is essential in recruiting Tel1p both to double-strand breaks (32) and to short telomeres (38). Interestingly, the mammalian functional homologue of Xrs2p, NBS1, interacts with ATM via its extreme C terminus (13), suggesting that the recruitment of Tel1p to telomeres and the recruitment of ATM to DNA damage sites are conserved.It remains a question what exact roles the kinase activity of Tel1p and its telomere binding play in telomere maintenance. Tel1p''s telomere maintenance function seems to be dependent on its kinase activity, since tel1^KD cells have short telomeres (29). It has been proposed that Tel1p may regulate the recruitment of Est1p, and thus the rest of the telomerase complex (12, 23, 54), to telomeres by phosphorylating Cdc13p (3, 48). Other experiments suggest the association of Tel1p to the telomere plays a major role. The preferential binding of Tel1p to short telomeres is lost in xrs2-664 cells (38), which lack the C-terminal 190 amino acids of Xrs2p and have short telomeres, similar to xrs2Δ (41). It has been suggested that the association of Tel1p to telomeres is required for its substrate phosphorylation and, therefore, telomere length maintenance (3, 39).To further analyze the functions of Tel1p in telomere maintenance, we generated a novel kinase-dead allele of TEL1 and new alleles of XRS2 that do not interact with Tel1p. Through these separation-of-function mutants, we show that both sets of alleles are partially active in a de novo telomere elongation assay. However, combining both the tel1^KD and either of the Tel1p interaction-deficient xrs2 alleles resulted in a phenotype resembling the tel1Δ phenotype, suggesting that Tel1p has kinase-dependent and kinase-independent, but telomere binding-dependent, functions in telomere maintenance.     

BRCA1 Is Required for Maintenance of Phospho-Chk1 and G2/M Arrest during DNA Cross-Link Repair in DT40 Cells

The Fanconi anemia DNA repair pathway is pivotal for the efficient repair of DNA interstrand cross-links. Here, we show that FA-defective (Fancc⁻) DT40 cells arrest in G₂ phase following cross-link damage and trigger apoptosis. Strikingly, cell death was reduced in Fancc⁻ cells by additional deletion of the BRCA1 tumor suppressor, resulting in elevated clonogenic survival. Increased resistance to cross-link damage was not due to loss of toxic BRCA1-mediated homologous recombination but rather through the loss of a G₂ checkpoint. This proapoptotic role also required the BRCA1-A complex member ABRAXAS (FAM175A). Finally, we show that BRCA1 promotes G₂ arrest and cell death by prolonging phosphorylation of Chk1 on serine 345 after DNA damage to sustain arrest. Our data imply that DNA-induced cross-link death in cells defective in the FA pathway is dependent on the ability of BRCA1 to prolong cell cycle arrest in G₂ phase.     

Trf1 Is Not Required for Proliferation or Functional Telomere Maintenance in Chicken DT40 Cells

The telomere end-protection complex prevents the ends of linear eukaryotic chromosomes from degradation or inappropriate DNA repair. The homodimeric double-stranded DNA-binding protein, Trf1, is a component of this complex and is essential for mouse embryonic development. To define the requirement for Trf1 in somatic cells, we deleted Trf1 in chicken DT40 cells by gene targeting. Trf1-deficient cells proliferated as rapidly as control cells and showed telomeric localization of Trf2, Rap1, and Pot1. Telomeric G-strand overhang lengths were increased in late-passage Trf1-deficient cells, although telomere lengths were unaffected by Trf1 deficiency, as determined by denaturing Southern and quantitative FISH analysis. Although we observed some clonal variation in terminal telomere fragment lengths, this did not correlate with cellular Trf1 levels. Trf1 was not required for telomere seeding, indicating that de novo telomere formation can proceed without Trf1. The Pin2 isoform and a novel exon 4, 5–deleted isoform localized to telomeres in Trf1-deficient cells. Trf1-deficient cells were sensitive to DNA damage induced by ionizing radiation. Our data demonstrate that chicken DT40 B cells do not require Trf1 for functional telomere structure and suggest that Trf1 may have additional, nontelomeric roles involved in maintaining genome stability.     

The Principal Role of Ku in Telomere Length Maintenance Is Promotion of Est1 Association with Telomeres

Telomere length is tightly regulated in cells that express telomerase. The Saccharomyces cerevisiae Ku heterodimer, a DNA end-binding complex, positively regulates telomere length in a telomerase-dependent manner. Ku associates with the telomerase RNA subunit TLC1, and this association is required for TLC1 nuclear retention. Ku–TLC1 interaction also impacts the cell-cycle-regulated association of the telomerase catalytic subunit Est2 to telomeres. The promotion of TLC1 nuclear localization and Est2 recruitment have been proposed to be the principal role of Ku in telomere length maintenance, but neither model has been directly tested. Here we study the impact of forced recruitment of Est2 to telomeres on telomere length in the absence of Ku’s ability to bind TLC1 or DNA ends. We show that tethering Est2 to telomeres does not promote efficient telomere elongation in the absence of Ku–TLC1 interaction or DNA end binding. Moreover, restoration of TLC1 nuclear localization, even when combined with Est2 recruitment, does not bypass the role of Ku. In contrast, forced recruitment of Est1, which has roles in telomerase recruitment and activation, to telomeres promotes efficient and progressive telomere elongation in the absence of Ku–TLC1 interaction, Ku DNA end binding, or Ku altogether. Ku associates with Est1 and Est2 in a TLC1-dependent manner and enhances Est1 recruitment to telomeres independently of Est2. Together, our results unexpectedly demonstrate that the principal role of Ku in telomere length maintenance is to promote the association of Est1 with telomeres, which may in turn allow for efficient recruitment and activation of the telomerase holoenzyme.     

Telomere maintenance and tumorigenesis: an "ALT"ernative road

The acquisition of cellular immortality is a critical step in human tumorigenesis. While the vast majority of human tumors activate the catalytic component of telomerase (hTERT) to stabilize their telomeres and attain immortality, a significant portion (7-10%) utilize a poorly defined alternative form of telomere maintenance referred to as ALT. Interestingly, telomerase activation is often favored in tumors arising from the epithelial compartment whereas ALT occurs in a more significant portion of tumors that arise from tissues of mesenchymal origin. This observation raises the possibility that cell type specific mechanisms favor the activation of telomerase versus ALT in human tumorigenesis. Because cellular immortality is critical to tumorigenesis it may represent an important anti-neoplastic target. Indeed, several approaches have successfully eliminated telomerase activity in human tumor models and some of these approaches are now moving into clinical trials. While these results are encouraging, it is clear that these approaches will have no impact on cells that utilize the ALT mechanism for telomere maintenance. Furthermore, the existence of ALT raises the possibility that telomerase-positive tumors undergoing anti-telomerase therapies may escape by activating the ALT pathway. For these reasons a detailed understanding of the ALT pathway is critical to the future design of anti-neoplastic therapies.     

人类早期胚胎发育端粒维持初步研究

目的:探讨人类胚胎在早期发育过程中端粒维持的机制.方法:利用端粒特异性探针对临床IVF过程中2～8细胞时期停止发育不适合移植的胚胎和来自于囊胚期的人类胚胎干细胞进行荧光原位杂交检测端粒重组.结果:人类早期胚胎发育中存在端粒交换的结构APB小体,而来自于囊胚期的胚胎干细胞不再具有这种结构,胚胎干细胞端粒交换发生频率较低(...     

Telomere Structure,Replication and Length Maintenance

Telomeres are the termini of linear eukaryotic chromosomes consisting of tandem repeats of DNA and proteins that bind to these repeat sequences. Telomeres ensure the complete replication of chromosome ends, impart protection to ends from nucleolytic degradation, end-to-end fusion, and guide the localization of chromosomes within the nucleus. In addition, a combination of genetic, biochemical, and molecular biological approaches have implicated key roles for telomeres in diverse cellular processes such as regulation of gene expression, cell division, cell senescence, and cancer. This review focuses on recent advances in our understanding of the organization of telomeres, telomere replication, proteins that bind telomeric DNA, and the establishment of telomere length equilibrium.     

BRCA1 Pathway Function in Basal-Like Breast Cancer Cells

Sporadic basal-like cancers (BLCs) are a common subtype of breast cancer that share multiple biological properties with BRCA1-mutated breast tumors. Despite being BRCA1^+/+, sporadic BLCs are widely viewed as phenocopies of BRCA1-mutated breast cancers, because they are hypothesized to manifest a BRCA1 functional defect or breakdown of a pathway(s) in which BRCA1 plays a major role. The role of BRCA1 in the repair of double-strand DNA breaks by homologous recombination (HR) is its best understood function and the function most often implicated in BRCA1 breast cancer suppression. Therefore, it is suspected that sporadic BLCs exhibit a defect in HR. To test this hypothesis, multiple DNA damage repair assays focused on several types of repair were performed on a group of cell lines classified as sporadic BLCs and on controls. The sporadic BLC cell lines failed to exhibit an overt HR defect. Rather, they exhibited defects in the repair of stalled replication forks, another BRCA1 function. These results provide insight into why clinical trials of poly(ADP-ribose) polymerase (PARP) inhibitors, which require an HR defect for efficacy, have been unsuccessful in sporadic BLCs, unlike cisplatin, which elicits DNA damage that requires stalled fork repair and has shown efficacy in sporadic BLCs.     

Interplay among BRCA1, SIRT1, and Survivin during BRCA1-associated tumorigenesis

Germline mutations of BRCA1 predispose women to breast and ovarian cancers. However, the downstream mediators of BRCA1 function in tumor suppression remain elusive. We found that human BRCA1-associated breast cancers have lower levels of SIRT1 than their normal controls. We further demonstrated that mammary tumors from Brca1 mutant mice have low levels of Sirt1 and high levels of Survivin, which is reversed by induced expression of Brca1. BRCA1 binds to the SIRT1 promoter and increases SIRT1 expression, which in turn inhibits Survivin by changing the epigenetic modification of histone H3. Absence of SIRT1 blocks the regulation of Survivin by BRCA1. Furthermore, we demonstrated that activation of Sirt1 and inhibition of Survivin expression by resveratrol elicit a more profound inhibitory effect on Brca1 mutant cancer cells than on Brca1-wild-type cancer cells both in vitro and in vivo. These findings suggest that resveratrol treatment serves as an excellent strategy for targeted therapy for BRCA1-associated breast cancer.     

Telomere Structure,Function, and Maintenance in Plants

Telomeres in eukaryotes comprise specific repetitive DNA sequences and binding proteins. Since their absence results in chromosomal end fusions and gene deletions, they are considered critical for genomic stability. In plants, as in yeasts and mammals, telomeres are essential for normal development and differentiation. Despite recent discoveries concerning plant telomeres, many questions remain about the mechanism of telomere homeostasis in plants. In this review, we summarize the roles of telomeres and telomerasebinding proteins in plant biology and explain how the length of a plant telomere is regulated.     

BLM helicase-dependent and -independent roles of 53BP1 during replication stress-mediated homologous recombination

Mutations in BLM helicase cause Bloom syndrome, characterized by predisposition to all forms of cancer. We demonstrate that BLM, signal transducer 53BP1, and RAD51 interact during stalled replication. Interactions between the three proteins have functional consequences. Lack of 53BP1 decreases the cell survival and enhanced chromosomal aberration after replication arrest. 53BP1 exhibits both BLM-dependent and -independent anti-recombinogenic functions in human and mouse cells. Both BLM and 53BP1 abrogate endogenous RAD51 foci formation and disrupt RAD51 polymerization. Consequently, loss of BLM and 53BP1 synergistically enhances stress-dependent homologous recombination. These results provide evidence regarding the cooperation between BLM and 53BP1 during maintenance of genomic integrity.